| Term 
 
        | What are the mechanisms of Each of the HIV Drugs |  | Definition 
 
        | Enfuvirtide: Fusion Inhibitor Miraviroc: CCR5 Inhibition Raltegravir: Integrase inhibitor Zidovudine, Lamivudine, Emtricitabine, Abacavir: (NRTI) 2,3-dideoxyanalogs phosphorylated to triphosphates-Block active site Tenofovir: Nucleotide analog Efavirenz, Delavirdine, Nevirapine: Non-nucleoside Reverse Transcriptase inhibitors Ritonavir, Lopinavir, Amprenavir: inhibits through dipeptide region of aspirtate Protease |  | 
        |  | 
        
        | Term 
 
        | Adverse effects of Maraviroc |  | Definition 
 
        | Heart Attack URI Hepatotoxic P450   |  | 
        |  | 
        
        | Term 
 
        | Adverse Effects fo Enfuvirtide |  | Definition 
 
        | Bacterial Pneumonia Injection only(site rxn) |  | 
        |  | 
        
        | Term 
 
        | What factors affect the absorption of Raltegravir |  | Definition 
 
        | Rifampin and divalent cations reduce absorption |  | 
        |  | 
        
        | Term 
 
        | What are the general adverse effects of NRTI's |  | Definition 
 
        | Need Renal function Gamma-Polymerase Block in Mito Lactic Acidosis Lipid Dystrophy Peripheral neuropathy Myopathy: Fatigue, prox weakness, myalgia Dialated Cardiomyopathy Liver Steatosis Pancreatitis |  | 
        |  | 
        
        | Term 
 
        | What are adverse effects specific to zidovudine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are adverse effects specific to Abacavir |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are adverse effects specific to Efavirenz |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the site effects common to NNRTI's |  | Definition 
 
        | Rash(Steven-Johnson) Hepatitis(Nevirapine)(At drug onset) P450 Induction |  | 
        |  | 
        
        | Term 
 
        | What are the general side effects of the protease inhibitors |  | Definition 
 
        | GI: Nausea, vomit, diarrhea Hyperglycemia: Insulin resistance Lipodystrophy: central obesity, cushingoid Hyperlipidemia: (Ritonavir is worst) Osetonecrosis, Osteopenia, Osteoporosis Hepatotoxicity(At any time) Inhibit P450 |  | 
        |  | 
        
        | Term 
 
        | What is protease inhibitor boosting |  | Definition 
 
        | *Ritonavir is use in concert with another Protease inhibitor to inhannce efficacy Use of Ritonavir decreases the metabolism of certain protease inhibitors(Amprenavir) and increases the absorption of others by blocking p-GP in the intestine(Lopinavir) |  | 
        |  | 
        
        | Term 
 
        | What are the preferred drug regimens for HIV patients? |  | Definition 
 
        | NNRTI based: Either/or Efavirenz w/ Tenofovir/Emtricitabine or Efavirenz w/ Zidovudine/Lamivudine 
 PI based: Either/or Lopinavir/Ritonavir w/ Tenofovir/Emtricitabine Lopinavir/Ritonavir w/ Zidovudine/Lamivudine |  | 
        |  | 
        
        | Term 
 
        | What ART drugs for HIV should not be used in combination |  | Definition 
 
        |   Stavudine and Zidovudine(Kinase competition) Zalcitabine and Didanosine(Peripheral Neuropathy additive)     |  | 
        |  |